Acupuncture to Prevent Postoperative Bowel Paralysis (Paralytic Ileus) - Tabular View

Tracking Information

First Received Date ^ICMJE

July 18, 2003

Last Updated Date

August 16, 2006

Start Date ^ICMJE

September 2003

Primary Completion Date

Current Primary Outcome Measures ^ICMJE

Original Primary Outcome Measures ^ICMJE

Change History

Complete list of historical versions of study NCT00065234 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^ICMJE

Original Secondary Outcome Measures ^ICMJE

Descriptive Information

Brief Title ^ICMJE

Acupuncture to Prevent Postoperative Bowel Paralysis (Paralytic Ileus)

Official Title ^ICMJE

Acupuncture to Prevent Postoperative Paralytic Ileus

Brief Summary

The purpose of this study is to determine if acupuncture is effective in preventing prolonged postoperative paralysis of the gastrointestinal tract among patients undergoing colostomy/ileostomy closure.

Detailed Description

Study Phase

Phase II

Study Type ^ICMJE

Interventional

Study Design ^ICMJE

Prevention, Randomized, Single Blind, Active Control, Parallel Assignment, Efficacy Study

Condition ^ICMJE

Ileus
Neoplasms

Intervention ^ICMJE

Procedure: Acupuncture

Study Arms / Comparison Groups

Publications *

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Suspended

Enrollment ^ICMJE

100

Completion Date

May 2006

Primary Completion Date

Eligibility Criteria ^ICMJE

Inclusion Criteria:

Previous surgical cancer treatment with ileostomy/colostomy, now scheduled for closure
Hospital admission must be same day as surgery

Exclusion Criteria:

Incapacitating disease
Concurrent herbal or laxative use
Use of Heparin or Coumadin
Upper or lower extremity deformities
Chronic constipation prior to cancer diagnosis
History of cerebrovascular accident or spinal cord injury
Chronic pain that has been treated with any form of major opioid or weak opioids (=/> 30mg/24 hours)
Pacemaker or metal implants
Concurrent alternative medicine/herbal use

Gender

Both

Ages

18 Years and older

Accepts Healthy Volunteers

Contacts ^ICMJE

Contact information is only displayed when the study is recruiting subjects

Location Countries ^ICMJE

United States

Administrative Information

NCT ID ^ICMJE

NCT00065234

Responsible Party

Study ID Numbers ^ICMJE

R21 AT001065-01A1, ChiangJ

Study Sponsor ^ICMJE

National Center for Complementary and Alternative Medicine (NCCAM)

Collaborators ^ICMJE

Investigators ^ICMJE

Principal Investigator:

Joseph S Chiang, MD

M.D. Anderson Cancer Center

Information Provided By

National Center for Complementary and Alternative Medicine (NCCAM)

Verification Date

August 2006

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP